In states of obesity and metabolic dysfunction, NNMT is often overexpressed in adipose tissue, depleting nicotinamide and reducing NAD+ availability
We evaluate at the end of each cycle before deciding whether to repeat, adjust the dose, add a stack partner like TB-500, or transition to a maintenance approach
Chronic Conditions That Respond Well Certain chronic conditions appear particularly suited to the micro-dosing approach
The solution should be clear once dissolved
GLP-1-based compounds work primarily through appetite suppression, and the weight loss they produce includes significant lean mass loss (approximately 40% of total weight lost is lean tissue based on STEP trial data)
Joint and Muscle Repair Supports tendon and ligament healing, reducing downtime from injuries Enhances flexibility and mobility in athletes and active individuals May aid recovery in degenerative conditions like arthritis 3